Kite Pharma, Inc. Deferred Tax Assets, Valuation Allowance, Noncurrent
Kite Pharma, Inc. had Deferred Tax Assets, Valuation Allowance, Noncurrent of $40.16 million as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent · last filed 2016-02-29
- 2015-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $40.16M.
- 2014-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $16.36M.
| Period end | Deferred Tax Assets, Valuation Allowance, Noncurrent |
|---|---|
| 2015-12-31 | $40.16M 10-K · filed 2016-02-29 |
| 2014-12-31 | $16.36M 10-K · filed 2016-02-29 |